Article

Balenciaga, Safilo sign licensing agreement

Padua, Italy?Balenciaga and Safilo Group have entered into a worldwide licensing partnership for Balenciaga eyewear. The agreement runs through the end of 2012.

Balenciaga and Safilo have already collaborated to develop eyewear styles for Balenciaga's spring-summer 2007 fashion show. The initial collection featured women's sunglasses, two of which were developed specifically for the fashion show while the third was a rerelease of vintage 1970s Balenciaga eyewear.

The license formalizes their partnership with plans to launch a full line of sunglasses starting in autumn 2007, with optical frames to follow.

Isabelle Guichot, president and chief executive officer, Balenciaga, noted: "We have been delighted by the quality and constructiveness of our collaboration with Safilo. We look forward to consolidating the partnership among our creativity, the very high quality of Safilo's products, and the clear selectivity of their distribution."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.